← Back to headlines
BeOne Medicines' Liver Cancer Asset Granted Orphan Drug Status
BeOne Medicines announced that its asset for liver cancer has been granted orphan drug status, a designation that provides incentives for developing drugs for rare diseases.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
